APA (7th ed.) Citation

T, M., A, A., M, A., R, S., A, V., J, C., . . . D, M. (2022). Public health and budgetary impact of 20-valent pneumococcal conjugate vaccine for adults in England. Expert review of vaccines, 21(9), 1331. https://doi.org/10.1080/14760584.2022.2104250

Chicago Style (17th ed.) Citation

T, Mugwagwa, et al. "Public Health and Budgetary Impact of 20-valent Pneumococcal Conjugate Vaccine for Adults in England." Expert Review of Vaccines 21, no. 9 (2022): 1331. https://doi.org/10.1080/14760584.2022.2104250.

MLA (9th ed.) Citation

T, Mugwagwa, et al. "Public Health and Budgetary Impact of 20-valent Pneumococcal Conjugate Vaccine for Adults in England." Expert Review of Vaccines, vol. 21, no. 9, 2022, p. 1331, https://doi.org/10.1080/14760584.2022.2104250.